Prosecution Insights
Last updated: October 02, 2026

Examiner: LEE, DAVINA EN-YIN

Tech Center 3700 • Art Units: 3794

This examiner grants 39% of resolved cases

Analysis

Davina En-Yin Lee is an examiner in Art Unit 3794, which is part of Tech Center 3700. She has 57 resolved cases, providing a focused view of her examination tendencies. The allowance rate for this examiner is 38.6 percent, which indicates a more challenging environment for patent applicants. However, the interview lift is 14.3 percent, suggesting that direct engagement with the examiner is a productive way to move an application toward allowance. This 14.3 percent lift is a significant incentive for practitioners to schedule interviews.

The median time to allowance is 1425 days, which is a long prosecution cycle of nearly four years. This 1425-day timeline, combined with the 38.6 percent allowance rate, highlights the difficulties of working in Art Unit 3794. However, the 14.3 percent interview lift provides a clear path to improving those odds. With 57 resolved cases, the data reflects a consistent examination style where communication is key. Practitioners should use the lift to resolve any outstanding issues and potentially shorten the long delays indicated by the 1425-day median pendency. The data from Tech Center 3700 suggests that the interview is a critical tool for success. The 1425-day median pendency remains the primary benchmark for expected prosecution length.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

38.6%
Allow Rate
-31.4% vs TC avg
100
Total Applications
+14.3%
Interview Lift
1425
Avg Prosecution Days
Based on 57 resolved cases, 2023–2026

Rejection Statute Breakdown

0.9%
§101 Eligibility
10.7%
§102 Novelty
58.0%
§103 Obviousness
28.9%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
19172370 ELECTRIC FIELD APPLICATION FOR SINGLE SHOT CARDIAC ABLATION BY IRREVERSIBLE ELECTROPORATION Non-Final OA Boston Scientific Scimed, Inc
18419107 ELECTRODE EDGE TRANSITION TO IMPROVE CURRENT DENSITY Final Rejection Boston Scientific Scimed, Inc.
18717140 APPARATUS FOR CONTROLLING A TREATMENT DEVICE AND SYSTEM COMPRISING A TREATMENT DEVICE Non-Final OA KONINKLIJKE PHILIPS N.V.
18853415 Flexible Microelectrode Arrays Non-Final OA Nikon Corporation
17552432 IMAGE-ASSISTED SENSOR SELECTION IN THE CAPACITIVE MEASUREMENT OF BIOELECTRICAL SIGNALS Non-Final OA Siemens Healthcare GmbH
18702014 Implantable Medical Device for Sensing Physiological Signals Final Rejection BIOTRONIK SE & Co. KG
18151693 NON-DRYING ELECTROLYTE GELS FOR SOFT ELECTRODES Final Rejection Meta Platforms Technologies, LLC
18055481 BASKET CATHETER WITH FORCE SENSOR HAVING BAYONET MOUNT Non-Final OA Biosense Webster (Israel) Ltd.
17825233 PORT AND DEPTH STOP AND TIP FEATURES FOR TRANSSEPTAL PUNCTURE APPARATUS Final Rejection Biosense Webster (Israel) Ltd.
17479272 ABLATING A REGION OF PATIENT ORGAN USING SELECTED ABLATION ELECTRODES OF AN EXPANDABLE CATHETER Final Rejection BIOSENSE WEBSTER (ISRAEL) LTD.
17441597 Thin-Film Lead Assemblies And Neural Interfaces Non-Final OA Verily Life Sciences LLC
18717501 HANDLING DEVICE FOR AN ELECTROSURGICAL INSTRUMENT, METHOD FOR PRODUCING A HANDLING DEVICE, AND ELECTROSURGICAL INSTRUMENT Final Rejection KARL STORZ SE & Co. KG
17344780 ALIGNMENT TOOL FOR CHEST-WORN SENSOR DEVICE Final Rejection Analog Devices, Inc.
17704347 Medical Device Final Rejection TERUMO KABUSHIKI KAISHA
17403811 CATHETER SYSTEMS AND RELATED METHODS FOR MAPPING, MINIMIZING, AND TREATING CARDIAC FIBRILLATION Final Rejection University of Vermont and State Agricultural College
18870608 BIOLOGICAL SENSOR Non-Final OA NITTO DENKO CORPORATION
17626058 MEDICAL DEVICE Final Rejection CAMBRIDGE ENTERPRISE LIMITED
17674212 SYSTEMS AND METHODS FOR NERVE FIBER CONDUCTION BLOCK Final Rejection Duke University

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month